First Melanoma Test To Offer Reassurance Of Low Risk Of Cancer Spread
Source: Medical Dialogues, January 2022
A pioneering test which reliably predicts the spread or return of the most deadly form of skin cancer has been developed by a team of Newcastle scientists and clinicians.
The technological advance came as they made a scientific breakthrough in understanding the mechanism of skin cancer growth.
Led by Professor Penny Lovat at Newcastle University, UK, in association with the University spin out company AMLo Biosciences, the test offers reassurance for patients diagnosed with an early stage melanoma.